Sera Prognostics, Inc. - Class A Common Stock

Share · US81749D1072 · SERA (XNAS)

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of Sera Prognostics, Inc. - Class A Common Stock

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

29.04.2026 18:45

Current Prices from Sera Prognostics, Inc. - Class A Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	SERA	USD	29.04.2026 18:45	1,95 USD	-0,03 USD -1,52 %
IEX	SERA	USD	28.04.2026 19:58	2,07 USD	0,07 USD +3,50 %

Share Float & Liquidity

Free Float 70,61 %

Shares Float 26,96 M

Shares Outstanding 38,18 M

Company Profile for Sera Prognostics, Inc. - Class A Common Stock Share

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.